KR100601073B1 - 5-ｈｔ1ａ 수용체 서브타입 작용물질 - Google Patents

5-ｈｔ1ａ 수용체 서브타입 작용물질 Download PDF

Info

Publication number
KR100601073B1
KR100601073B1 KR1020037008565A KR20037008565A KR100601073B1 KR 100601073 B1 KR100601073 B1 KR 100601073B1 KR 1020037008565 A KR1020037008565 A KR 1020037008565A KR 20037008565 A KR20037008565 A KR 20037008565A KR 100601073 B1 KR100601073 B1 KR 100601073B1
Authority
KR
South Korea
Prior art keywords
delete delete
disorder
disease
drug
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020037008565A
Other languages
English (en)
Korean (ko)
Other versions
KR20030065570A (ko
Inventor
조단샤운
기꾸찌데쯔로
도또리가쯔라
히로세쯔요시
우와호도야스후미
Original Assignee
오쓰까 세이야꾸 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25087808&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR100601073(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 오쓰까 세이야꾸 가부시키가이샤 filed Critical 오쓰까 세이야꾸 가부시키가이샤
Publication of KR20030065570A publication Critical patent/KR20030065570A/ko
Application granted granted Critical
Publication of KR100601073B1 publication Critical patent/KR100601073B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Toxicology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020037008565A 2001-01-29 2002-01-29 5-ｈｔ1ａ 수용체 서브타입 작용물질 Expired - Lifetime KR100601073B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77021001A 2001-01-29 2001-01-29
US09/770,210 2001-01-29
PCT/JP2002/000626 WO2002060423A2 (en) 2001-01-29 2002-01-29 Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists

Related Child Applications (2)

Application Number Title Priority Date Filing Date
KR1020067005164A Division KR100763288B1 (ko) 2001-01-29 2002-01-29 5-ｈｔ1ａ 수용체 서브타입 작용물질
KR1020057019896A Division KR100653591B1 (ko) 2001-01-29 2002-01-29 5-ｈｔ1ａ 수용체 서브타입 작용물질

Publications (2)

Publication Number Publication Date
KR20030065570A KR20030065570A (ko) 2003-08-06
KR100601073B1 true KR100601073B1 (ko) 2006-07-19

Family

ID=25087808

Family Applications (5)

Application Number Title Priority Date Filing Date
KR1020037008565A Expired - Lifetime KR100601073B1 (ko) 2001-01-29 2002-01-29 5-ｈｔ1ａ 수용체 서브타입 작용물질
KR1020077010561A Expired - Lifetime KR100825705B1 (ko) 2001-01-29 2002-01-29 5-ｈｔ1ａ 수용체 서브타입 작용물질
KR1020057019896A Expired - Lifetime KR100653591B1 (ko) 2001-01-29 2002-01-29 5-ｈｔ1ａ 수용체 서브타입 작용물질
KR1020067014046A Expired - Lifetime KR100713607B1 (ko) 2001-01-29 2002-01-29 5-ｈｔ1ａ 수용체 서브타입 작용물질
KR1020067005164A Ceased KR100763288B1 (ko) 2001-01-29 2002-01-29 5-ｈｔ1ａ 수용체 서브타입 작용물질

Family Applications After (4)

Application Number Title Priority Date Filing Date
KR1020077010561A Expired - Lifetime KR100825705B1 (ko) 2001-01-29 2002-01-29 5-ｈｔ1ａ 수용체 서브타입 작용물질
KR1020057019896A Expired - Lifetime KR100653591B1 (ko) 2001-01-29 2002-01-29 5-ｈｔ1ａ 수용체 서브타입 작용물질
KR1020067014046A Expired - Lifetime KR100713607B1 (ko) 2001-01-29 2002-01-29 5-ｈｔ1ａ 수용체 서브타입 작용물질
KR1020067005164A Ceased KR100763288B1 (ko) 2001-01-29 2002-01-29 5-ｈｔ1ａ 수용체 서브타입 작용물질

Country Status (19)

Country Link
EP (3) EP1621198B1 (https=)
JP (4) JP4178032B2 (https=)
KR (5) KR100601073B1 (https=)
CN (3) CN1239154C (https=)
AR (4) AR032641A1 (https=)
AT (3) ATE504293T1 (https=)
AU (4) AU2002226752C1 (https=)
BR (1) BR0206237A (https=)
CA (2) CA2429496C (https=)
CY (3) CY1105631T1 (https=)
DE (3) DE60239711D1 (https=)
DK (3) DK1712225T3 (https=)
ES (3) ES2363366T3 (https=)
MX (2) MX344556B (https=)
MY (1) MY129355A (https=)
PH (1) PH12014500937A1 (https=)
PT (3) PT1621198E (https=)
TW (2) TWI331919B (https=)
WO (1) WO2002060423A2 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053092B2 (en) 2001-01-29 2006-05-30 Otsuka Pharmaceutical Co., Ltd. 5-HT1a receptor subtype agonist
AR032641A1 (es) * 2001-01-29 2003-11-19 Otsuka Pharma Co Ltd Agonista de subtipo de receptor 5-ht 1a.
US8703772B2 (en) 2001-09-25 2014-04-22 Otsuka Pharmaceutical Co., Ltd. Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
DE10148233A1 (de) * 2001-09-28 2003-04-10 Boehringer Ingelheim Pharma Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme
AU2003268026A1 (en) * 2002-07-30 2004-02-16 Peter Migaly Combination therapy for depression, prevention of suicide, and varous medical and psychiatric conditions
AR042806A1 (es) * 2002-12-27 2005-07-06 Otsuka Pharma Co Ltd Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo
CN1989968B (zh) * 2002-12-27 2011-05-11 大塚制药株式会社 用于治疗情绪障碍的喹诺酮衍生物和5-羟色胺再摄取抑制剂
CN102166359A (zh) * 2003-05-23 2011-08-31 大塚制药株式会社 用于治疗情感障碍的喹诺酮衍生物和情绪稳定剂
US7160888B2 (en) 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
FR2865650B1 (fr) * 2004-01-30 2008-06-13 Biocortech Utilisation du 14,15 dihydro 20,21-dinoreburnamenin14-ol pour traiter et/ou prevenir les depressions majeures et les desordres du cycle veille-sommeil
WO2006090273A2 (en) * 2005-02-22 2006-08-31 Warner-Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds with keto or hydroxyl linkers for the treatment of schizophrenia
ES2646326T3 (es) * 2005-08-03 2017-12-13 Sprout Pharmaceuticals, Inc. Uso de flibanserina en el tratamiento de la obesidad
TW200848041A (en) * 2007-03-30 2008-12-16 Otsuka Pharma Co Ltd A medicament for treating schizophrenia comprising cilostazol
GB2456183A (en) 2008-01-04 2009-07-08 Gw Pharma Ltd Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament
JP2009286740A (ja) * 2008-05-30 2009-12-10 Otsuka Pharmaceut Co Ltd アリピプラゾールを含有する逆耐性抑制剤
EP2338873A1 (en) 2009-12-22 2011-06-29 Gmeiner, Peter New aminotetraline derivatives
AR090245A1 (es) 2012-03-06 2014-10-29 Otsuka Pharma Co Ltd Preparacion solida oral de liberacion sostenida, metodo de preparacion
JOP20200109A1 (ar) 2012-04-23 2017-06-16 Otsuka Pharma Co Ltd مستحضر قابل للحقن

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54130587A (en) 1978-03-30 1979-10-09 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
JPS5646812A (en) * 1979-09-27 1981-04-28 Otsuka Pharmaceut Co Ltd Central nervous system depressant
US4764416A (en) 1986-07-01 1988-08-16 Mitsubishi Denki Kabushiki Kaisha Electric element circuit using oxidation-reduction substances
US5006528A (en) * 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
JP2608788B2 (ja) * 1988-10-31 1997-05-14 大塚製薬 株式会社 精神分裂病治療剤
WO1992020655A1 (en) * 1991-05-20 1992-11-26 The Upjohn Company Carboxamido-(1,2n)-carbocyclic-2-aminotetralin derivatives
US5532240A (en) * 1991-12-26 1996-07-02 Yoshitomi Pharmaceutical Industries, Ltd. Condensed thiophene compound and pharmaceutical use thereof
WO1994009765A1 (en) * 1992-10-23 1994-05-11 New York University Functional interactions between glial s-100b and central nervous system serotonergic neurons
DK148292D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Forbindelser
JP2959615B2 (ja) * 1993-06-24 1999-10-06 吉富製薬株式会社 縮合型チオフェン化合物およびその医薬用途
JPH09291034A (ja) * 1996-02-27 1997-11-11 Yoshitomi Pharmaceut Ind Ltd 縮合ピリジン化合物およびその医薬としての用途
US5688950A (en) * 1996-04-23 1997-11-18 Neurogen Corporation Tricyclic aminoalkylcarboxamides; novel dopamine D3 receptor subtype specific ligands
US6110918A (en) * 1996-05-07 2000-08-29 Pfizer Inc Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihy dro-2(1H)-indol-2-one (=ziprasidone), its preparation and its use as dopamine D2 antagonist
JP4012994B2 (ja) * 1996-05-08 2007-11-28 大塚製薬株式会社 抗不安薬
JP2000516936A (ja) * 1996-08-27 2000-12-19 アメリカン・ホーム・プロダクツ・コーポレイション ドパミンｄ２作動薬としておよび５―ｈｔ１ａリガンドとしての４―アミノエトキシインドール
EP1053235A1 (en) * 1998-02-03 2000-11-22 American Home Products Corporation Oxazole derivatives as serotonin-1a receptor agonists
WO1999052870A1 (en) * 1998-04-13 1999-10-21 American Home Products Corporation 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists
JPH11335286A (ja) * 1998-05-25 1999-12-07 Mitsui Chem Inc ドーパミン拮抗薬の効果増強剤
AR032641A1 (es) * 2001-01-29 2003-11-19 Otsuka Pharma Co Ltd Agonista de subtipo de receptor 5-ht 1a.
EA009780B1 (ru) * 2001-06-19 2008-04-28 Норберт Мюллер Применение ингибиторов cox-2 для лечения шизофрении, аффективных расстройств или осложнений, связанных с тиком
AR033485A1 (es) * 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma

Also Published As

Publication number Publication date
HK1061805A1 (en) 2004-10-08
DK1712225T3 (da) 2011-06-20
CN1484524A (zh) 2004-03-24
AU2005201772C1 (en) 2010-06-03
CA2700314C (en) 2012-04-24
TW200522960A (en) 2005-07-16
JP2007297405A (ja) 2007-11-15
ES2286755T3 (es) 2007-12-01
KR20070065425A (ko) 2007-06-22
KR100713607B1 (ko) 2007-05-02
BR0206237A (pt) 2003-12-23
CA2700314A1 (en) 2002-08-08
TWI331919B (en) 2010-10-21
ATE362763T1 (de) 2007-06-15
DE60239711D1 (de) 2011-05-19
TWI302832B (en) 2008-11-11
AU2002226752B2 (en) 2005-03-17
DE60210581D1 (en) 2006-05-24
HK1091403A1 (zh) 2007-01-19
CA2429496A1 (en) 2002-08-08
MX344556B (es) 2016-12-20
AU2007201701A1 (en) 2007-05-10
ES2261652T3 (es) 2006-11-16
AR099754A2 (es) 2016-08-17
EP1621198A3 (en) 2006-04-12
AU2002226752C1 (en) 2010-02-18
AR080849A2 (es) 2012-05-09
KR100825705B1 (ko) 2008-04-29
AU2009233591A1 (en) 2009-11-19
JP4178032B2 (ja) 2008-11-12
EP1621198B1 (en) 2007-05-23
JP2011184460A (ja) 2011-09-22
AR032641A1 (es) 2003-11-19
JP4896831B2 (ja) 2012-03-14
PH12014500937A1 (en) 2015-09-21
EP1355639A2 (en) 2003-10-29
JP5683010B2 (ja) 2015-03-11
KR20030065570A (ko) 2003-08-06
EP1712225A1 (en) 2006-10-18
KR100653591B1 (ko) 2006-12-05
DK1355639T3 (da) 2006-08-14
AU2007201701B2 (en) 2010-06-17
PT1355639E (pt) 2006-06-30
AU2005201772A1 (en) 2005-05-19
KR100763288B1 (ko) 2007-10-04
JP2004517937A (ja) 2004-06-17
AR079761A2 (es) 2012-02-15
AU2009233591B2 (en) 2011-10-20
DE60220325D1 (de) 2007-07-05
JP2011225587A (ja) 2011-11-10
DK1621198T3 (da) 2007-09-24
CN1239154C (zh) 2006-02-01
CN100450485C (zh) 2009-01-14
CY1105631T1 (el) 2010-12-22
WO2002060423A3 (en) 2003-04-10
WO2002060423A2 (en) 2002-08-08
ATE504293T1 (de) 2011-04-15
PT1621198E (pt) 2007-06-08
MY129355A (en) 2007-03-30
DE60210581T2 (de) 2007-04-05
EP1355639B1 (en) 2006-04-12
MXPA03006603A (es) 2004-02-12
ES2363366T3 (es) 2011-08-02
CY1108031T1 (el) 2013-09-04
AU2005201772B2 (en) 2007-05-17
DE60220325T2 (de) 2008-01-17
KR20060085260A (ko) 2006-07-26
CA2429496C (en) 2010-10-19
PT1712225E (pt) 2011-04-18
KR20060028485A (ko) 2006-03-29
KR20050107822A (ko) 2005-11-15
ATE322894T1 (de) 2006-04-15
EP1712225B1 (en) 2011-04-06
CN1879624A (zh) 2006-12-20
EP1621198A2 (en) 2006-02-01
CY1111392T1 (el) 2015-08-05
CN1813745A (zh) 2006-08-09

Similar Documents

Publication Publication Date Title
US8426423B2 (en) Method of treating Attention Deficit Hyper-Activity Disorder
JP5683010B2 (ja) ５−ｈｔ１ａ受容体サブタイプ作動薬
AU2002226752A1 (en) Substituted carbostyril derivatives as 5-HT1A receptor subtype agonists
AU2013203248A1 (en) Substituted carbostyril derivatives as 5-HT 1A receptor subtype agonists

Legal Events

Date Code Title Description
A201 Request for examination
AMND Amendment
PA0105 International application

Patent event date: 20030624

Patent event code: PA01051R01D

Comment text: International Patent Application

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20050726

Patent event code: PE09021S01D

A107 Divisional application of patent
AMND Amendment
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20051017

A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20051020

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20060211

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20050726

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

A107 Divisional application of patent
AMND Amendment
J201 Request for trial against refusal decision
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20060314

PJ0201 Trial against decision of rejection

Patent event date: 20060314

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20060211

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20060509

Appeal identifier: 2006101002242

Request date: 20060314

PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20060314

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20060314

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20051017

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 20030624

Patent event code: PB09011R02I

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

Patent event date: 20060509

Comment text: Decision to Grant Registration

Patent event code: PB07012S01D

Patent event date: 20060420

Comment text: Transfer of Trial File for Re-examination before a Trial

Patent event code: PB07011S01I

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20060707

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20060707

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20090623

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20090623

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20100707

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20100707

Start annual number: 5

End annual number: 5

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20110412

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20060707

Comment text: Registration of Establishment

Decision date: 20110817

Request date: 20110412

Appeal identifier: 2011100000831

Appeal kind category: Confirmation of the scope of right_affirmative

FPAY Annual fee payment

Payment date: 20110617

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20110617

Start annual number: 6

End annual number: 6

J301 Trial decision

Free format text: TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_AFFIRMATIVE REQUESTED 20110412

Effective date: 20110817

Free format text: TRIAL NUMBER: 2011100000831; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_AFFIRMATIVE REQUESTED 20110412

Effective date: 20110817

PJ1301 Trial decision

Patent event code: PJ13011S02D

Patent event date: 20110817

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_affirmative

Request date: 20110412

Decision date: 20110817

Appeal identifier: 2011100000831

FPAY Annual fee payment

Payment date: 20120621

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20120621

Start annual number: 7

End annual number: 7

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20130613

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20060707

Comment text: Registration of Establishment

Decision date: 20130830

Request date: 20130613

Appeal identifier: 2013100001573

Appeal kind category: Confirmation of the scope of right_affirmative

FPAY Annual fee payment

Payment date: 20130621

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20130621

Start annual number: 8

End annual number: 8

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20131022

Request date: 20130731

Appeal identifier: 2013100002035

Appeal kind category: Confirmation of the scope of right_affirmative

Decision date: 20130927

Request date: 20130731

Appeal identifier: 2013100002034

Appeal kind category: Confirmation of the scope of right_affirmative

Patent event code: PJ02062R01D

Patent event date: 20130731

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20060707

Comment text: Registration of Establishment

Decision date: 20130925

Request date: 20130731

Appeal identifier: 2013100002033

Appeal kind category: Confirmation of the scope of right_affirmative

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20130830

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2013100001573

Request date: 20130613

Appeal kind category: Confirmation of the scope of right_affirmative

Decision date: 20130830

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20130925

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2013100002033

Request date: 20130731

Appeal kind category: Confirmation of the scope of right_affirmative

Decision date: 20130925

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20130927

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2013100002034

Request date: 20130731

Appeal kind category: Confirmation of the scope of right_affirmative

Decision date: 20130927

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20131022

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2013100002035

Request date: 20130731

Appeal kind category: Confirmation of the scope of right_affirmative

Decision date: 20131022

FPAY Annual fee payment

Payment date: 20140626

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20140626

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20150618

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20150618

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20160616

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20160616

Start annual number: 11

End annual number: 11

FPAY Annual fee payment

Payment date: 20170616

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20170616

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20180615

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20180615

Start annual number: 13

End annual number: 13

FPAY Annual fee payment

Payment date: 20190617

Year of fee payment: 14

PR1001 Payment of annual fee

Payment date: 20190617

Start annual number: 14

End annual number: 14

FPAY Annual fee payment

Payment date: 20200618

Year of fee payment: 15

PR1001 Payment of annual fee

Payment date: 20200618

Start annual number: 15

End annual number: 15

FPAY Annual fee payment

Payment date: 20210617

Year of fee payment: 16

PR1001 Payment of annual fee

Payment date: 20210617

Start annual number: 16

End annual number: 16

EXPY Expiration of term
PC1801 Expiration of term